First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 3.75 GBX Market Closed
Updated: Apr 26, 2024

Wall Street
Price Targets

FAB Price Targets Summary
Fusion Antibodies PLC

There are no price targets for FAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Fusion Antibodies PLC Competitors:
Price Targets
603127
Joinn Laboratories China Co Ltd
48% Upside
PPGN
PolyPeptide Group AG
27% Downside
SEER
Seer Inc
308% Upside
300030
Improve Medical Instruments Co Ltd
203% Upside
688046
GemPharmatech Co Ltd
92% Upside
MRVI
Maravai LifeSciences Holdings Inc
32% Upside
TECN
Tecan Group AG
23% Upside
4YL
Nanoform Finland Oyj
64% Upside

Revenue
Forecast

Revenue Estimate
Fusion Antibodies PLC

For the last 7 years the compound annual growth rate for Fusion Antibodies PLC's revenue is 10%. The projected CAGR for the next 1 year is -43%.

10%
Past Growth
-43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Fusion Antibodies PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Fusion Antibodies PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FAB's stock price target?
Not Available

FAB doesn't have any price targets made by Wall Street professionals.

What is Fusion Antibodies PLC's Revenue forecast?
Projected CAGR
-43%

For the last 7 years the compound annual growth rate for Fusion Antibodies PLC's revenue is 10%. The projected CAGR for the next 1 year is -43%.